Both in Biotechnology
Humacyte vs Protara Therapeutics
Over the past year HUMA returned −72.3% and TARA returned −51.1%; their daily moves had a correlation of 0.17.
HUMA −72.3% TARA −51.1%Growth of $1, one year, split-adjusted
| Metric | HUMA | TARA |
|---|---|---|
| Price | $0.4701 | $2.49 |
| Market cap | $130.6M | $147.1M |
| Today | +5.33% | +0.81% |
| 1 month | −11.8% | −22.4% |
| 6 months | −42.7% | −51.8% |
| Year to date | −51.1% | −53.3% |
| 1 year | −72.0% | −51.4% |
| Revenue growth (YoY) | +34.9% | — |
| Gross margin | −203.2% | — |
| Net margin | −9064.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 61.6× | — |
| Net cash | $13.7M | $142.5M |
| Dividend yield | — | — |
| Volatility (60d) | 103.1% | 49.2% |
| Short % of float | 11.9% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).